CASI Pharmaceuticals, Inc. To Participate In Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Rhea-AI Summary

CASI Pharmaceuticals, Inc. (Nasdaq: CASI) announced that Dr. Alexander Zukiwski, Chief Medical Officer, will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 21, 2021, at 12:05 PM (EDT). The presentation will be accessible via CASI's website under 'Events & Presentations', with archived replays available for 90 days. CASI is focused on developing therapeutics in hematology oncology and expanding its reach into global markets, especially China, leveraging its regulatory and commercial expertise.

ROCKVILLE, Md. and BEIJING, Sept. 20, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announced that Dr. Alexander Zukiwski, Chief Medical Officer of CASI Pharmaceuticals, will be presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. Details for the virtual conference is as follows.

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Tuesday, September 21^st
Time: 12:05 PM (EDT)

Webcast or external link of the company presentation will be available under "Events & Presentations" in the "Investors Relations" section of CASI's website. Archived replays will be available for approximately 90 days following the event.

About CASI Pharmaceuticals

CASI Pharmaceuticals, Inc. is a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world. The Company is focused on acquiring, developing and commercializing products that augment its hematology oncology therapeutic focus as well as other areas of unmet medical need. The Company intends to execute its plan to become a leader by launching medicines in the greater China market leveraging the Company's China-based regulatory and commercial competencies and its global drug development expertise. The Company's operations in China are conducted through its wholly-owned subsidiary, CASI Pharmaceuticals (China) Co., Ltd., which is located in Beijing, China. The Company has built a commercial team of more than 100 hematology and oncology sales and marketing specialists based in China. More information on CASI is available at www.casipharmaceuticals.com.

COMPANY CONTACT: CASI Pharmaceuticals, Inc. 240.864.2643 ir@casipharmaceuticals.com

INVESTOR CONTACT: Solebury Trout Bob Ai 646-378-2926 bai@soleburytrout.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/casi-pharmaceuticals-inc-to-participate-in-oppenheimer-fall-healthcare-life-sciences--medtech-summit-301379920.html

SOURCE CASI Pharmaceuticals, Inc.

FAQ

When is CASI Pharmaceuticals presenting at the Oppenheimer Summit?

CASI Pharmaceuticals will present on September 21, 2021, at 12:05 PM (EDT) during the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit.

Who is presenting for CASI Pharmaceuticals at the Oppenheimer Summit?

Dr. Alexander Zukiwski, Chief Medical Officer of CASI Pharmaceuticals, will be presenting at the summit.

Where can I watch CASI Pharmaceuticals' presentation?

The presentation will be available on CASI's website under 'Events & Presentations'.

How long will the CASI Pharmaceuticals presentation be archived?

Archived replays of the CASI Pharmaceuticals presentation will be available for approximately 90 days after the event.

What is the focus of CASI Pharmaceuticals?

CASI Pharmaceuticals focuses on developing innovative therapeutics, particularly in hematology oncology, and expanding in global markets.